Morphine sulfate and Methenamine hippurate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Morphine sulfate and Methenamine hippurate. Common interactions include escherichia urinary tract infection among females and platelet count decreased among males.

The phase IV clinical study analyzes what interactions people who take Morphine sulfate and Methenamine hippurate have. It is created by eHealthMe based on reports of 7 people who take Morphine sulfate and Methenamine hippurate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 02, 2023

7 people who take Morphine sulfate and Methenamine hippurate together, and have interactions are studied.


What is Morphine sulfate?

Morphine sulfate has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 71,624 Morphine sulfate users for its effectiveness, alternative drugs and more.

What is Methenamine hippurate?

Methenamine hippurate has active ingredients of methenamine hippurate. It is often used in urinary tract infection. eHealthMe is studying from 832 Methenamine hippurate users for its effectiveness, alternative drugs and more.

Number of Morphine sulfate and Methenamine hippurate reports submitted per year:

Morphine sulfate and Methenamine hippurate drug interactions.

Common Morphine Sulfate and Methenamine Hippurate drug interactions by gender *:

female:

  1. Escherichia urinary tract infection
  2. Gastric disorder
  3. Mental status changes
  4. Nausea
  5. Urinary tract infection enterococcal

male:

  1. Platelet count decreased
  2. Blood creatinine increased
  3. Neuropathy peripheral

Common Morphine Sulfate and Methenamine Hippurate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Escherichia urinary tract infection
  2. Mental status changes
  3. Nausea
  4. Platelet count decreased
  5. Urinary tract infection enterococcal

* Approximation only. Some reports may have incomplete information.

Do you take Morphine sulfate and Methenamine hippurate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Morphine sulfate and Methenamine hippurate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Morphine sulfate side effects:

Browse all side effects of Morphine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Methenamine hippurate side effects:

Browse all side effects of Methenamine hippurate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Morphine sulfate interactions:

Browse all interactions between Morphine sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Methenamine hippurate interactions:

Browse all interactions between Methenamine hippurate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate and methenamine hippurate (the active ingredients of Morphine sulfate and Methenamine hippurate, respectively), and Morphine sulfate and Methenamine hippurate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Morphine sulfate and Methenamine hippurate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: